İpek Yönal Hindilerden

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

M. Beksac, L. Kaynar, E. Gündüz, 2021, Turkish journal of haematology : official journal of Turkish Society of Haematology.

A Rare Cause of Unexplained Refractory Iron Deficiency Anemia: Unicentric Plasma-Cell Type Castleman’s Disease

I. Dogan, F. Beşışık, F. Hindilerden, 2016, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

B. Ferhanoğlu, Didar Yanardağ Açık, S. Başcı, 2021, Journal of chemotherapy.

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

B. Ferhanoğlu, G. Yegen, M. Yenerel, 2022, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Budd-Chiari Syndrome: An Unusual Complication of AL Amyloidosis

G. Yegen, T. Tiryaki, M. Nalçacı, 2020, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Evaluation of the Effect of NQO1 C609T (rs1800566) Gene Variations in Philadelphia-negative Myeloproliferative Neoplasms in Turkish Population

A. Yavuz, O. Öztürk, H. Yilmaz Aydogan, 2020 .

Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

H. Bekoz, S. Kalayoglu-besisik, T. Tiryaki, 2023, The European Research Journal.